PortfoliosLab logoPortfoliosLab logo
ISIN
US71742Q1067
CUSIP
71742Q106
IPO Date
Apr 11, 2014

Highlights

Market Cap
$1.28B
Enterprise Value
$1.82B
EPS (TTM)
$2.33
PE Ratio
13.34
PEG Ratio
0.03
Total Revenue (TTM)
$1.50B
Gross Profit (TTM)
$488.12M
EBITDA (TTM)
$219.25M
Year Range
$24.59 - $60.08
Target Price
$49.00
ROA (TTM)
6.59%
ROE (TTM)
26.32%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

PAHC Performance Chart

Phibro Animal Health Corporation (PAHC) is down 16.3% since the beginning of the year. At $31 per share, PAHC is trading 48.3% below its 52-week high of $60. Investors who bought $1,000 worth of PAHC shares 5 years ago would now be looking at an investment worth $1,228.


Loading charts...

S&P 500 Index

Returns By Period

Phibro Animal Health Corporation (PAHC) has returned -16.29% so far this year and 31.75% over the past 12 months. Over the last ten years, PAHC has returned 7.28% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Phibro Animal Health Corporation

1D
-2.45%
1M
-6.19%
YTD
-16.29%
6M
-17.33%
1Y
31.75%
3Y*
35.22%
5Y*
4.20%
10Y*
7.28%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PAHC Monthly Returns History

Based on dividend-adjusted daily data since Apr 11, 2014, PAHC's average daily return is +0.07%, while the average monthly return is +1.32%. At this rate, an investment would double in approximately 4.4 years.

Historically, 60% of months were positive and 40% were negative. The best month was Aug 2025 with a return of +39.9%, while the worst month was May 2026 at -42.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, PAHC closed higher 50% of trading days. The best single day was Apr 29, 2024 with a return of +31.8%, while the worst single day was Aug 28, 2019 at -31.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20267.47%35.97%1.55%-3.85%-42.10%1.34%-16.29%
20253.86%4.26%-5.60%-12.87%31.22%5.11%3.76%39.89%9.50%3.95%-0.16%-10.79%80.76%
2024-6.65%19.61%0.88%29.16%5.57%-4.21%12.58%11.23%7.89%2.66%1.60%-10.14%86.30%
202314.84%2.79%-2.48%1.57%-14.52%3.95%5.69%-3.66%-7.70%-14.49%-11.15%20.75%-10.42%
2022-5.48%10.36%-5.81%-9.82%7.44%-0.42%2.30%-24.32%-9.52%10.53%-15.36%8.94%-32.33%
20216.80%4.00%13.72%0.49%14.97%2.89%-18.04%3.14%-11.32%1.86%-10.23%4.24%7.28%

Benchmark Metrics

Phibro Animal Health Corporation has an annualized alpha of 5.06%, beta of 0.92, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since April 11, 2014.

  • This stock participated in 81.60% of S&P 500 Index downside but only 66.74% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
5.06%
Beta
0.92
0.13
Upside Capture
66.74%
Downside Capture
81.60%

Return for Risk

Risk / Return Rank

PAHC ranks 59 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


PAHC Risk / Return Rank: 5959
Overall Rank
PAHC Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
PAHC Sortino Ratio Rank: 5858
Sortino Ratio Rank
PAHC Omega Ratio Rank: 6161
Omega Ratio Rank
PAHC Calmar Ratio Rank: 5656
Calmar Ratio Rank
PAHC Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PAHCBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.49

Sortino ratioReturn per unit of downside risk

-1.61

Omega ratioGain probability vs. loss probability

1.16

1.37

-0.21

Calmar ratioReturn relative to maximum drawdown

0.61

2.78

-2.17

Martin ratioReturn relative to average drawdown

1.84

12.44

-10.60

Dividends

Dividend History

Phibro Animal Health Corporation provided a 1.54% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 11 consecutive years.


1.00%1.50%2.00%2.50%3.00%3.50%4.00%4.50%$0.00$0.10$0.20$0.30$0.40$0.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.42$0.40$0.40$0.40

Dividend yield

1.54%1.28%2.29%4.15%3.58%2.35%2.47%1.93%1.31%1.19%1.37%1.33%

Monthly Dividends

The table displays the monthly dividend distributions for Phibro Animal Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.12$0.00$0.00$0.12$0.24
2025$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2024$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2023$0.00$0.12$0.00$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2022$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2021$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.48

Dividend Yield & Payout


Dividend Yield

Phibro Animal Health Corporation has a dividend yield of 1.54%, which is quite average when compared to the overall market.

Payout Ratio

Phibro Animal Health Corporation has a payout ratio of 20.43%, which is below the market average. This means Phibro Animal Health Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Phibro Animal Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Phibro Animal Health Corporation was 79.62%, occurring on Nov 10, 2023. Recovery took 500 trading sessions.

The current Phibro Animal Health Corporation drawdown is 47.63%.


Related event

Drawdown

Fall

Recovery

Underwater

2023 bear market2023
-79.62%Nov 2023
5y 2mo2y 1d
7y 2moAug 2018 - Nov 2025
2016 bear market2016
-54.80%May 2016
9mo 9d1y 2mo
1y 11moAug 2015 - Aug 2017
2026 bear market2026
-52.13%Jun 2026
1mo 19d
2mo 10dApr 2026 - now
2014 bear market2014
-21.85%Aug 2014
1mo 26d2mo 4d
4moJun 2014 - Oct 2014
2018 correction2018
-19.03%Feb 2018
5mo 21d28d
6mo 19dAug 2017 - Mar 2018

Drawdown Indicators


PAHCBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-79.62%

-56.78%

-22.84%

Max Drawdown (1Y)

Largest decline over 1 year

-52.13%

-9.10%

-43.03%

Max Drawdown (3Y)

Largest decline over 3 years

-52.13%

-18.90%

-33.23%

Max Drawdown (5Y)

Largest decline over 5 years

-65.63%

-25.43%

-40.20%

Max Drawdown (10Y)

Largest decline over 10 years

-79.62%

-33.92%

-45.70%

Current Drawdown

Current decline from peak

-47.63%

-1.80%

-45.83%

Average Drawdown

Average peak-to-trough decline

-39.01%

-10.71%

-28.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.29%

2.03%

+15.26%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Phibro Animal Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Phibro Animal Health Corporation is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PAHC, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/E ratio of 13.3. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PAHC compared to other companies in the Drug Manufacturers - Specialty & Generic industry. PAHC currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PAHC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PAHC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/B value of 3.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PAHC

Add Phibro Animal Health Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PAHC